A landmark 2026 clinical decision tool published by Mavroudis and colleagues is reshaping how neurologists — and personal injury attorneys — assess epilepsy risk after traumatic brain injury. For years, insurance adjusters and defense teams have relied on the word “mild” to suppress settlement values in TBI cases. New biomarker-driven prediction models are dismantling that strategy, and plaintiffs who understand the science stand to recover significantly more in post-traumatic epilepsy mild TBI settlement damages.
Why “Mild” TBI Epilepsy Risk Is a Litigation Blind Spot in 2026
The phrase “mild traumatic brain injury” creates a dangerous misconception in personal injury litigation. Defense attorneys routinely argue that a mild TBI carries minimal long-term consequences — a position that crumbles when confronted with current neurological evidence. According to the CDC, traumatic brain injury affects millions of Americans each year, and even injuries classified as “mild” can trigger permanent neurological conditions, including epilepsy.
Post-traumatic epilepsy (PTE) — defined as recurrent, unprovoked seizures occurring after a traumatic brain injury — develops in less than 1 to 10 percent of mild TBI survivors and a consistently higher 6 to 12 percent of moderate TBI survivors, according to 2025 reports. Approximately half of all cases emerge within the first year following injury. These are not rare outliers. They represent a statistically significant and foreseeable complication that responsible damage calculations must address. When insurers dismiss this risk, they are ignoring both the medical literature and the long-term financial burden placed on injury survivors.
The legislative landscape is also shifting in plaintiffs’ favor. In July 2026, the House passed the bipartisan Traumatic Brain Injury Program Reauthorization Act (H.R. 1493), reauthorizing federal programs supporting those living with TBIs through 2030. This signals growing national recognition that TBI — including mild TBI — demands sustained medical and legal attention. Understanding the full scope of these risks is essential when using a personal injury settlement calculator to estimate compensation — because generic calculators that ignore neurological sequelae will routinely undervalue these claims.
The Mavroudis 2026 Clinical Decision Tool: What It Changes for Plaintiffs
The Mavroudis et al. clinical decision tool, published in 2026, represents one of the most significant advances in PTE risk stratification to date. The tool integrates five structured domains: injury severity, early post-traumatic seizures, neuroimaging findings, clinical and demographic variables, and EEG abnormalities. Its purpose is to help clinicians identify which patients are at highest risk of developing epilepsy — but its implications extend directly into the courtroom. By providing a reproducible, peer-reviewed framework for quantifying epilepsy risk in mild and moderate TBI patients, the Mavroudis tool gives plaintiff attorneys a powerful evidentiary foundation that defense teams cannot easily dismiss.
How AI-Assisted Risk Stratification Strengthens Damages Arguments
The Mavroudis model incorporates several validated risk factors that courts have historically underweighted. These include the presence of early post-traumatic seizures, contusions involving the temporal or frontal lobes, subdural hematomas, and prolonged loss of consciousness. When a plaintiff’s neuroimaging and EEG findings are scored against this five-domain framework, the resulting risk profile becomes difficult for defense experts to minimize. In 2026, TBI settlement amounts typically range from $20,000 for mild cases to over $10 million for catastrophic injuries, with some verdicts and settlements exceeding $26 million. The Mavroudis tool helps explain why — and helps justify — recovery at the higher end of that spectrum when documented epilepsy risk is present.
Robert Callahan is a TBI and Catastrophic Injury Researcher with extensive knowledge of personal injury law and settlement values across the United States. With years of experience analyzing brain injury / tbi claims only cases, Robert helps injury victims understand their legal rights and the potential value of their claims. Robert is not an attorney and the information provided is for educational purposes only.